An evaluation of health benefit modification in Taft-Hartley health and welfare funds: implications for encouraging tobacco-cessation coverage
- PMID: 21074675
- DOI: 10.1016/j.amepre.2010.09.010
An evaluation of health benefit modification in Taft-Hartley health and welfare funds: implications for encouraging tobacco-cessation coverage
Abstract
Background: An estimated one fifth of all U.S. adult smokers receive health benefits through insurance plans administered by Taft-Hartley Health and Welfare Funds. Most funds do not offer comprehensive tobacco-cessation services to fund participants despite evidence that doing so would be cost effective and save lives.
Purpose: This paper examines the decision-making processes of Minnesota-based fund trustees and advisors to identify factors that influence decisions about modifications to benefits.
Methods: Formative data about the process by which funds make health benefit modifications were collected in 2007-2008 from 25 in-depth key informant interviews with fund trustees and a cross-section of fund advisors, including administrators, attorneys, and healthcare business consultants. Analyses were performed using a general inductive approach to identify conceptual themes, employing qualitative data analysis software.
Results: The most commonly cited factors influencing trustees' decisions about health plan benefit modifications-including modifications regarding tobacco-cessation benefits-were benefit costs, participants' demand for services, and safeguarding participants' health. Barriers included information gaps, concerns about participants' response, and difficulty projecting benefit utilization and success. Advisors wielded considerable influence in decision-making processes.
Conclusions: Trustees relied on a small pool of business, legal, and administrative advisors to provide guidance and recommendations about possible health plan benefit modifications. Providing advisors with evidence-based information and resources about benefit design, cost/return-on-investment (ROI), effectiveness, and promotion may be an effective means to influence funds to provide comprehensive tobacco-cessation benefits.
Copyright © 2010 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Smoking cessation in a blue-collar population: results from an evidence-based pilot program.Am J Ind Med. 2002 Nov;42(5):367-77. doi: 10.1002/ajim.10129. Am J Ind Med. 2002. PMID: 12382249
-
Influencing Taft-Hartley Funds to provide tobacco cessation benefits.Am J Prev Med. 2012 Nov;43(5 Suppl 3):S237-41. doi: 10.1016/j.amepre.2012.07.034. Am J Prev Med. 2012. PMID: 23079222
-
The demand for health insurance coverage for tobacco dependence treatments: support for a benefit mandate and willingness to pay.Nicotine Tob Res. 2007 Dec;9(12):1269-76. doi: 10.1080/14622200701705621. Nicotine Tob Res. 2007. PMID: 18058345
-
Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?Expert Rev Pharmacoecon Outcomes Res. 2009 Jun;9(3):257-64. doi: 10.1586/erp.09.28. Expert Rev Pharmacoecon Outcomes Res. 2009. PMID: 19527098 Review.
-
[Efficacy and cost-effectiveness of smoking cessation courses in the statutory health insurance: a review].Gesundheitswesen. 2009 Nov;71(11):732-8. doi: 10.1055/s-0029-1214400. Epub 2009 Jun 2. Gesundheitswesen. 2009. PMID: 19492280 Review. German.
Cited by
-
Public Health Policy in Support of Insurance Coverage for Smoking Cessation Treatments.Healthc Policy. 2017 May;12(4):56-68. doi: 10.12927/hcpol.2017.25098. Healthc Policy. 2017. PMID: 28617238 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
